Sebia Overview
- Founded
-
1967
- Status
-
Private
- Employees
-
1,000
- Latest Deal Type
-
Debt
- Financing Rounds
-
9
- Investments
-
1
Sebia General Information
Description
Provider of clinical protein electrophoresis equipment and reagents technology designed to use for in-vitro diagnostic testing. The company analyzes proteins in order to screen and monitors various diseases and conditions such as oncology, metabolic disorders, hemoglobinopathy and rare pathologies, enabling laboratories to make electrophoresis accessible with simply performing systems.
Contact Information
Website
www.sebia.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Diagnostic Equipment
Primary Office
- 27 rue Léonard de Vinci
- 91008 Lisses
- France
+33 01 00 00 00 00
Sebia Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sebia Patents
Sebia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2805740-T3 | Electrophoresis method with immunofixation with gel immuno-displacement of target components | Active | 27-Jul-2016 | 0000000000 | |
| CA-3031595-A1 | Improved immunofixation electrophoresis method with target component on-gel immunodisplacement | Pending | 27-Jul-2016 | 0000000000 | |
| US-20190242891-A1 | Improved immunofixation electrophoresis method with target component on-gel immunodisplacement | Pending | 27-Jul-2016 | 0000000000 | |
| EP-3276351-B1 | Immunofixation electrophoresis method with target component on-gel immunodisplacement | Active | 27-Jul-2016 | 0000000000 | |
| EP-3276351-A1 | Immunofixation electrophoresis method with target component on-gel immunodisplacement | Granted | 27-Jul-2016 | G01N33/561 | 0 |
Sebia Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jean-Marc Chermette | President & Chief Executive Officer | ||
| Pierre Sonigo | Chief Scientific Officer | ||
| David Martyr Ph.D | Chairman |
Sebia Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 000000 00.0 | Self | Chairman | 000 0000 |
Sebia Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Sebia Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sebia Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 0000 | 08-Sep-2021 | 0000000000 | Laboratory Services (Healthcare) | 0000-0000 |
Sebia Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000000 000000000 | Laboratory Services (Healthcare) | Mainz, Germany | 0000 |